Cancer Family
Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000022Explore in graph →
Non-malignant4,304 active trials98 approved drugs1,010 evidence items
- NCIt
- C35813
Loading cancer entity…
Cancer Family
CI-CAN-00000022Explore in graph →
Clinical trials
18,827 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01296178 | PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years | unknown | N/A | 200 | PETHEMA FoundationOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT01288222 | Selecting a Favorable KIR Donor in Unrelated HCT for AML | completed | N/A | 506 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT04792593 |
| Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia |
| unknown |
| N/A |
| 15 |
| Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY |
| 1 |
| Mar 11, 2021 |
| clinicaltrials |
| NCT03493906 | Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment(PAS) | completed | N/A | 61 | Rigshospitalet, DenmarkOTHER | 1 | Mar 10, 2021 | clinicaltrials |
| NCT04692948 | TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia | unknown | N/A | 5 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04785833 | CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia | unknown | N/A | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Mar 8, 2021 | clinicaltrials |
| NCT01807091 | Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome | completed | N/A | 17 | University of WashingtonOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT03562910 | Mobile-based Social Services Screening and Referral Tool in an Pediatric Emergency Department | completed | N/A | 266 | Boston Children's HospitalOTHER | 1 | Mar 2, 2021 | clinicaltrials |
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04758442 | Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology(Hemato-Vanco) | unknown | N/A | 40 | Ciusss de L'Est de l'Île de MontréalOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT04663516 | Effectiveness of Exercise Through Video Games in Reducing Fatigue Among Children With Leukemia | completed | N/A | 46 | King Saud UniversityOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT00943800 | Combined Haploidentical-Cord Blood Transplantation for Adults and Children | completed | N/A | 87 | University of ChicagoOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04723342 | Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot | unknown | N/A | 180 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | terminated | N/A | 330 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT00525057 | Dalteparin in Preventing DVT in Participants With Cancer | completed | N/A | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT03955848 | INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS(NKAML) | unknown | N/A | 80 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT03889483 | Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion | unknown | N/A | 105 | Dr. Michael EsserOTHER | 1 | Jan 13, 2021 | clinicaltrials |
| NCT04701554 | EFFECT OF A 16-SESSION QIGONG PROGRAM ON PHYSICAL AND MENTAL HEALTH IN PATIENTS WITH LYMPHOMA: A RANDOMIZED CONTROLLED TRIAL | completed | N/A | 39 | Consuelo Lourdes Díaz RodríguezOTHER | 1 | Jan 8, 2021 | clinicaltrials |
| NCT04665063 | A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 29, 2020 | clinicaltrials |
| NCT02710565 | Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma(EBUS) | completed | N/A | 22 | Mid and South Essex NHS Foundation TrustOTHER | 1 | Dec 23, 2020 | clinicaltrials |
| NCT02439112 | Exercise in Patients With Multiple Myeloma(EMMY) | completed | N/A | 102 | Zealand University HospitalOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03804164 | Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04336501 | Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation | unknown | N/A | 20 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04666168 | A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma | unknown | N/A | 200 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 14, 2020 | clinicaltrials |
| NCT04160442 | Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL | completed | N/A | 46 | Carevive Systems, Inc.INDUSTRY | 1 | Dec 11, 2020 | clinicaltrials |
| NCT04665076 | Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors | unknown | N/A | 60 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 11, 2020 | clinicaltrials |
| NCT04100070 | Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Study(DEEP) | unknown | N/A | 320 | ISIS Diabete ServiceOTHER | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04323605 | Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant(AMA-ALLO) | unknown | N/A | 50 | University Hospital, ToulouseOTHER | 1 | Dec 3, 2020 | clinicaltrials |
| NCT03981510 | Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation | unknown | N/A | 80 | University of AarhusOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT00741455 | Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies | completed | N/A | 18 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Nov 23, 2020 | clinicaltrials |
| NCT01171430 | "WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival(EVALICEMM) | completed | N/A | 104 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT04620655 | RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL | unknown | N/A | 24 | Min XiangOTHER | 1 | Nov 9, 2020 | clinicaltrials |
| NCT04617145 | Aerobic Versus Resistive Training on Functional Capacity in Acute Myeloid Leukemia | completed | N/A | 60 | Cairo UniversityOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT04610125 | Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children | unknown | N/A | 30 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Oct 30, 2020 | clinicaltrials |
| NCT00859586 | Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation | completed | N/A | 8 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Oct 27, 2020 | clinicaltrials |
| NCT04503538 | Telemedicine for Early Detection of Cytokine Release Syndrome and Neurotoxicity | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Oct 23, 2020 | clinicaltrials |
| NCT02410252 | Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies | completed | N/A | 25 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT04595955 | Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life | completed | N/A | 99 | Radboud University Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT01815333 | Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging | completed | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT04590105 | The Impact of a Smartphone App on the Quality of Pediatric Colonoscopy Preparations | completed | N/A | 42 | Stony Brook UniversityOTHER | 0 | Oct 19, 2020 | clinicaltrials |
| NCT01064557 | "AIDA" Protocol (LAP 0493) | unknown | N/A | 1,068 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 5 | Oct 14, 2020 | clinicaltrials |
| NCT03380039 | Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma | unknown | N/A | 6 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT02192333 | Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors | completed | N/A | 390 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 9, 2020 | clinicaltrials |
| NCT03302403 | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | unknown | N/A | 18 | Kang YUOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03327285 | C-CAR011 Treatment in Subjects With ALL After HSCT | unknown | N/A | 40 | Peking University People's HospitalOTHER | 1 | Oct 1, 2020 | clinicaltrials |
| NCT04447547 | Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 29, 2020 | clinicaltrials |
| NCT04447573 | Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 29, 2020 | clinicaltrials |
| NCT04377828 | Improvement of Pigmented Skin Lesions in Patients With Mastocytosis After Performing 2 Sessions of Pigment Laser(LaserMasto) | unknown | N/A | 34 | University Hospital, ToulouseOTHER | 1 | Sep 25, 2020 | clinicaltrials |
| NCT00726830 | Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer | terminated | N/A | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 24, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Mar 23, 2021source: clinicaltrials